Yesterday Novo Nordisk agreed to pay up to $ 1.3 billion for their drug delivery technology in a deal that could cut the frequency that patients need to inject its obesity and diabetes drugs. I haven't sold a single share. Their patented Pharmashell © technology now has Moderna AND Novo behind their backs with signed license deals. There are few things which will stop Nanexa from becoming one of the biggest names in Swedish Pharma. Get in while it's still under 2$ my fellow regards. submi
CryptoAlerta — análise de criptomoedas e mercado em tempo real